News

 

At AseBio, we follow the latest news in the biotechnology sector and pass the highlights on to you. You can use the search engine to find news articles we’ve written, contributed by our members or from other stakeholders in the sector. And they are also organised into categories to help you find the topics you’re interested in easily.

Search engine
Multipartner-AseBio-Biotecnologia
#NewMemberAseBio | "AseBio is the major community of Spanish biotechnology that provides a favourable environment to protect innovation in the biotechnology sector and ensure the exploitation of patents"
Access to innovation
Meet r Multipartner Virtual Data Room, our new member. We talked to María del…
Bexen-AseBio
#NewMemberAseBio | "AseBio is the collective voice of the biotechnology sector"
Healthcare
Meet  Bexen Medical, our new member. We talked to Manuel Sánchez-…
AseBio - BEXEN MEDICAL
Oryzon-Asebio-Biotecnologia
ORYZON Announces Voting Results from its 2023 Annual General Meeting of Shareholders
Corporate
All resolutions were approved and 35% of the issued shares represented.
Partners - Oryzon Genomics
Biotecnología_AseBio
AseBio and EuropaBio address the challenges of the Pharmaceutical Strategy and NGTs in Europe
Healthcare · Agrifood
During the Presidency of the Council of the European Union, Spain will lead the dialogue on these…
Fundación_Medina_Welab_AseBio
WeLab Barcelona and Fundación MEDINA will collaborate to expand the offer of R&D services and capabilities for the discovery and development of new medicines
Innovative drugs
This collaboration allows combining experience and resources for the discovery and development of…
Partners - Fundación Medina
Kinsy-AseBio-biotecnologia
#NewMemberAseBio| "AseBio will keep us informed and updated on status of these markets and potential challenges and opportunities"
Healthcare · Access to innovation
Meet KINSY our new member. We talked to Alicia Hernández, Projects and…
Thomas_Harth_Ysios
Tagworks Pharmaceuticals Announces $64 Million in Series A Financing to Advance Click-to-Release Therapeutics
Access to innovation
Financing round led by Ysios Capital and Gilde Healthcare with participation from Novartis Venture…
Partners - Ysios Capital Partners
Oficina_Genesis_Biomed_Valencia
GENESIS Biomed opens a new office in Valencia
Corporate
This new location of GENESIS Biomed in the BioHub joins the existing locations in Barcelona and…
Partners - GENESIS Biomed
Laboratorio_Biotecnología_AseBio
‘JAMA Neurology’ publishes the results from Phase 1b/2a clinical trial of the neuroprotective drug ApTOLL for ischemic stroke
Healthcare
The results from APRIL study, previously presented at the International Stroke Conference 2023,…
Partners - AptaTargets